HPV-associated oropharyngeal cancers - Are they preventable?

Cancer Prevention Research

Volumn 4, Issue 9, 2011, Pages 1346-1349

  Kreimer, Aimée R ^a   Chaturvedi, Anil K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

CANCER CYTODIAGNOSIS; CANCER INHIBITION; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; MOUTH INFECTION; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PRECANCER; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SECONDARY PREVENTION; VACCINATION; WART VIRUS;

ADULT; AGED; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE;

EID: 80052599878     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0379     Document Type: Review

References (27)

1. Parkin D.M., Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006;24 Suppl 3:S11-S25 (Pubitemid 44404053)
2. Wang S.S., Sherman M.E., Hildesheim A., Lacey J.V. Jr, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004;100:1035-1044 (Pubitemid 38232621)
3. Johnson L.G., Madeleine M.M., Newcomer L.M., Schwartz S.M., Daling J.R. Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004;101:281-288 (Pubitemid 38890830)
4. Judson P.L., Habermann E.B., Baxter N.N., DurhamS.B., Virnig B.A. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 2006;107:1018-1022
5. Chaturvedi A.K., Engels E.A., Anderson W.F., Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26:612-619 (Pubitemid 351264356)
6. Gillison M.L., Chaturvedi A.K., Lowy D.R. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113:3036-3046
7. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., Hernandez B.Y., Xiao W., Kim E., et al. Human papillomavirus (HPV) and rising oropharyngeal cancer incidence in the United States. J Clin Oncol In press 2011.
8. Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907. (Pubitemid 47371147)
9. Fakhry C., Rosenthal B.T., Clark D.P., Gillison M.L. Associations between oral HPV16 infection and cytopathology: Evaluation of an oropharyngeal "Pap-test equivalent" in high-risk populations. Cancer Prev Res 2011;4:1378-1384
10. Rintala M., Grenman S., Puranen M., Syrjanen S. Natural history of oral papillomavirus infections in spouses: A prospective Finnish HPV Family Study. J Clin Virol 2006;35:89-94. (Pubitemid 43020959)
11. D'Souza G., Fakhry C., Sugar E.A., Seaberg E.C., Weber K., Minkoff H.L., et al. Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer 2007;121:143-150 (Pubitemid 46753862)
12. Fakhry C., Sugar E., D'Souza G., Gillison M. Two-week versus sixmonth sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort. PLoS One 2010;5:e11918.
13. Kreimer A.R., Bhatia R.K., Messeguer A.L., Gonzalez P., Herrero R., Giuliano A.R. Oral human papillomavirus in healthy individuals: A systematic review of the literature. Sex Transm Dis 2010;37: 386-391
14. Kreimer A.R., Clifford G.M., Boyle P., Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005;14: 467-475 (Pubitemid 40270113)
15. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-819 (Pubitemid 46333946)
16. Giuliano A.R., Lazcano-Ponce E., Villa L.L., Flores R., Salmeron J., Lee J.H., et al. The human papillomavirus infection in men study: Human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008;17:2036-2043
17. Nyitray A.G., Carvalho da Silva R.J., Baggio M.L., Lu B., Smith D., Abrahamsen M., et al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: The HPV in men (HIM) study. J Infect Dis 2011;203:49-57.
18. Hernandez B.Y., McDuffie K., Zhu X., Wilkens L.R., Killeen J., Kessel B., et al. Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev 2005;14:2550-2556 (Pubitemid 41752714)
19. Kreimer A.R., Villa A., Nyitray A.G., Abrahamsen M., Papenfuss M., Smith D., et al. The epidemiology of oral HPV infection among a multinationalsample of healthy men. Cancer Epidemiol Biomarkers Prev 2011;20:172-182
20. De Sanjose S., Diaz M., Castellsague X., Clifford G., Bruni L., Munoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 2007;7:453-459 (Pubitemid 46962343)
21. D'Souza G., Agrawal Y., Halpern J., Bodison S., Gillison M.L. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009;199:1263-1269
22. Fakhry C., D'Souza G., Sugar E., Weber K., Goshu E., Minkoff H., et al. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women. J Clin Microbiol 2006;44:4479-4485 (Pubitemid 44937082)
23. Paavonen J., Naud P., Salmeron J., Wheeler C.M., Chow S.N., Apter D., et al. Efficacy of human papillomavirus (HPV)-16/18 AS04- adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women. Lancet 2009; 374:301-314
24. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915-1927
25. Garland S.M., Hernandez-Avila M., Wheeler C.M., Perez G., Harper D.M., Leodolter S., et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356: 1928-1943 (Pubitemid 46740303)
26. Giuliano A.R., Palefsky J.M., Goldstone S., Moreira E.D. Jr, Penny M.E., Aranda C., et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011;364:401-411
27. Mayne S.T., Morse D.E., Winn D.M. Cancers of the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. p. 674-698